237 related articles for article (PubMed ID: 32525969)
1. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z
Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969
[TBL] [Abstract][Full Text] [Related]
2. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
3. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
4. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
[TBL] [Abstract][Full Text] [Related]
5. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
[TBL] [Abstract][Full Text] [Related]
6. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
7. A 2-year retrospective study on pleural effusions: A cancer centre experience.
Valerio E; Nunes W; Cardoso J; Santos A; Bovolim G; Domingos T; De Brot L; Saieg M
Cytopathology; 2019 Nov; 30(6):607-613. PubMed ID: 31306514
[TBL] [Abstract][Full Text] [Related]
8. [Thoracocentesis for the assessment of lung cancer with pleural effusion].
Martín Díaz E; Arnau Obrer A; Martorell Cebollada M; Cantó Armengod A
Arch Bronconeumol; 2002 Oct; 38(10):479-84. PubMed ID: 12372198
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
10. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India.
Awasthi A; Gupta N; Srinivasan R; Nijhawan R; Rajwanshi A
Cytopathology; 2007 Feb; 18(1):28-32. PubMed ID: 17250600
[TBL] [Abstract][Full Text] [Related]
11. Value of Ki67 immunostain in identification of malignancy in serous effusions.
Saleh H; Bober P; Tabaczka P
Diagn Cytopathol; 1999 Jan; 20(1):24-8. PubMed ID: 9884823
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology.
Xu Y; Hu AY; Wang SM; Wang Q; Pan YC; Zhang SH
Diagn Cytopathol; 2021 Sep; 49(9):997-1007. PubMed ID: 34019334
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
14. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
[TBL] [Abstract][Full Text] [Related]
15. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.
Hou T; Landon G; Stewart J; Roy-Chowdhuri S
Cancer Cytopathol; 2021 Jan; 129(1):75-82. PubMed ID: 32809259
[TBL] [Abstract][Full Text] [Related]
16. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
17. Investigating unilateral pleural effusions: the role of cytology.
Arnold DT; De Fonseka D; Perry S; Morley A; Harvey JE; Medford A; Brett M; Maskell NA
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262573
[TBL] [Abstract][Full Text] [Related]
18. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
Segal A; Sterrett GF; Frost FA; Shilkin KB; Olsen NJ; Musk AW; Nowak AK; Robinson BW; Creaney J
Pathology; 2013 Jan; 45(1):44-8. PubMed ID: 23222247
[TBL] [Abstract][Full Text] [Related]
19. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
Jha S; Sethy M; Adhya AK
Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
[TBL] [Abstract][Full Text] [Related]
20. Adequacy in pleural effusion: What is the minimum volume required for detection of malignant cells?
Jha S; Sethy M; Sharma G; Adhya AK
Diagn Cytopathol; 2022 Jun; 50(6):284-288. PubMed ID: 35362266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
